Cytek Biosciences

(NASDAQ) CTKB

Current Price$4.55

Market Cap$586.19M

Since IPO (2021)-76%

5 YearN/A

1 Year+23%

1 Month+4%

Cytek Biosciences Financials at a Glance

Market Cap

$586.19M

Revenue (TTM)

$201.49M

Net Income (TTM)

$66.54M

EPS (TTM)

$-0.52

P/E Ratio

-8.77

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$4.55

Volume

34,081

Open

$4.42

Price

$4.55

Volume

34,081

Open

$4.42

Previous Close

$4.55

Daily Range

$4.42 - $4.57

52-Week Range

$2.37 - $6.18

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$4.55

Volume

34,081

Open

$4.42

Previous Close

$4.55

Daily Range

$4.42 - $4.57

52-Week Range

$2.37 - $6.18

CTKB News

Why Shares of Cytek Biosciences Dropped This Week

James HalleyMay 12, 2023

CTKB: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cytek Biosciences

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

700

CEO

Wen Bin Jiang, PhD

Website

cytekbio.com

Headquarters

Fremont, CA 94538, US

CTKB Financials

Key Financial Metrics (TTM)

Gross Margin

52%

Operating Margin

-20%

Net Income Margin

-33%

Return on Equity

-18%

Return on Capital

-11%

Return on Assets

-14%

Earnings Yield

-11.40%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$586.19M

Shares Outstanding

128.55M

Volume

34.08K

Avg. Volume

743.61K

Financials (TTM)

Gross Profit

$104.46M

Operating Income

$40.38M

EBITDA

$17.39M

Operating Cash Flow

$4.69M

Capital Expenditure

$4.08M

Free Cash Flow

$8.77M

Cash & ST Invst.

$261.53M

Total Debt

$33.02M

Cytek Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$62.14M

+8.1%

Gross Profit

$32.88M

-2.3%

Gross Margin

52.92%

N/A

Market Cap

$586.19M

N/A

Market Cap/Employee

$884.14K

N/A

Employees

663

N/A

Net Income

$44.08M

-557.1%

EBITDA

$263.00K

+89.3%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$228.50M

-12.4%

Accounts Receivable

$72.13M

+19.0%

Inventory

$0.00

-100.0%

Long Term Debt

$21.35M

+148.2%

Short Term Debt

$11.67M

+38.7%

Return on Assets

-14.42%

N/A

Return on Invested Capital

-10.52%

N/A

Free Cash Flow

$1.77M

-262.0%

Operating Cash Flow

$771.00K

-138.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SRDXSurmodics, Inc.

SRDXSurmodics, Inc.$42.98+0.35%

VREXVarex Imaging Corporation

VREXVarex Imaging Corporation$11.65+5.62%

ANGOAngioDynamics, Inc.

ANGOAngioDynamics, Inc.$10.94+2.63%

CBLLCeriBell, Inc.

CBLLCeriBell, Inc.$20.16+4.73%

KIDSOrthoPediatrics Corp.

KIDSOrthoPediatrics Corp.$15.06+2.87%

LABStandard BioTools Inc.

LABStandard BioTools Inc.$0.93+4.69%

CLPTClearPoint Neuro, Inc.

CLPTClearPoint Neuro, Inc.$11.18+8.12%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SOFISoFi Technologies

SOFISoFi Technologies$16.10+0.04%

AAPLApple

AAPLApple$271.35+0.00%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.63+0.10%

MARAMara Holdings

MARAMara Holdings$11.99+0.12%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$63.54+0.03%

FFord Motor Company

FFord Motor Company$12.08-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.47+0.05%

Questions About CTKB

What is the current price of Cytek Biosciences?

Cytek Biosciences is trading at $4.55 per share.

What is the 52-week range for Cytek Biosciences?

Over the past 52 weeks, Cytek Biosciences has traded between $2.37 and $6.18.

How much debt does Cytek Biosciences have?

As of the most recent reporting period, Cytek Biosciences reported total debt of $33.02M.

How much cash does Cytek Biosciences have on hand?

Cytek Biosciences reported $90.85M in cash and cash equivalents in its most recent financial results.

What is Cytek Biosciences’s dividend yield?

Cytek Biosciences does not currently have a dividend yield.

Cytek Biosciences

Cytek Biosciences Financials at a Glance

CTKB News

Why Shares of Cytek Biosciences Dropped This Week

CTKB: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cytek Biosciences

CTKB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cytek Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CTKB

What is the current price of Cytek Biosciences?

What is the 52-week range for Cytek Biosciences?

How much debt does Cytek Biosciences have?

How much cash does Cytek Biosciences have on hand?

What is Cytek Biosciences’s dividend yield?

Premium Investing Services